(Press-News.org) Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children's Hospital Cancer Center in Boston.
The trial leaders will present the results of the Dana-Farber Cancer Institute ALL Consortium study, which involved nearly 500 patients under age 18 with B-precursor acute lymphoblastic leukemia (B-ALL), at the annual meeting of the American Society of Hematology (ASH) conference.
Trial participants received an initial course of "induction" chemotherapy for B-ALL, a cancer of the blood that is one of the most common cancers in children below age 15. After a month of treatment, the patients had a bone marrow sample sent for a test able to measure levels of leukemia that cannot be seen under a microscope.
Thirty-five of the patients were deemed to have a very high risk of relapsing because they retained relatively large numbers of leukemia cells as measured by this test. An additional 16 patients were also considered very high-risk because their leukemia cells had certain chromosomal abnormalities.
These 51 patients then received an intensified treatment regimen consisting of two additional rounds of chemotherapy using agents not typically given to newly diagnosed patients with B-ALL. This was followed by an intensified consolidation phase of therapy to keep the disease in remission, and then a standard maintenance phase to further deter the disease from returning.
Investigators estimate that, five years after reaching complete remission, the rate of event-free survival (a measure of survival without relapse or development of another cancer) was 76 percent for these very high-risk patients. By contrast, less than half of similar patients who receive standard chemotherapy reach the five-year mark without relapsing.
"Pediatric patients with B-ALL traditionally receive a standard course of chemotherapy if their risk of relapse is low, and a slightly intensified course if their risk is higher," says the study's lead author, Lynda Vrooman, MD, of Dana-Farber/Children's Hospital Cancer Center. "In this study, we identified a new risk group – those with a very high risk of relapse – and studied the effect of a novel, even more intensive chemotherapy regimen on their outcome."
"Though it involved a relatively small number of patients, the new trial is one of the first to show improved outcomes for this set of patients as a result of an intensified chemotherapy protocol," says senior author Lewis Silverman, MD, of Dana-Farber/Children's Hospital Cancer Center. Trial leaders will continue to track the study participants to gauge the durability of the remissions produced by the intensified treatment.
INFORMATION:
Co-authors of the study include Kristen Stevenson, MS, and Donna Neuberg, ScD, of Dana-Farber; Marian Harris, MD, of Boston Children's Hospital; and Stephen Sallan, MD, of Dana-Farber/Children's Hospital Cancer Center.
Dana-Farber/Children's Hospital Cancer Center
Since 1947, Boston Children's Hospital and Dana-Farber Cancer Institute have provided comprehensive care for children and adolescents with cancer through Dana-Farber/Children's Hospital Cancer Center. The two Harvard Medical School affiliates share a clinical staff that delivers inpatient care at Boston Children's and outpatient therapies at Dana-Farber's Jimmy Fund Clinic. The Boston Children's inpatient pediatric cancer service has 33 beds, including 13 designated for stem cell transplant patients.
Boston Children's is also the site of DF/CHCC inpatient clinical translational research in pediatric malignancies and has long supported the operation of an effective and productive stem cell transplant service. It has a long history of investment in and support of both clinical and basic cancer research, with more than $7.3 million in National Cancer Institute research support and 47,000 square feet of space devoted to cancer research. It is a recognized center of excellence in angiogenesis, cellular/molecular immunology, cancer genetics, and molecular signaling research.
END
Over past decades, many areas of the forested Amazon basin have become a patchwork of farms, pastures and second-growth forest as people have moved in and cleared land--but now many are moving out, in search of economic opportunities in newly booming Amazonian cities. The resulting depopulation of rural areas, along with spreading road networks and increased drought are causing more and bigger fires to ravage vast stretches, say researchers in a new study. The study, focusing on the Peruvian Amazon, is the latest to suggest that land-use changes and other factors, including ...
Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome, scientists reported at the American Society of Hematology annual meeting.
In a study of 315 patients from a German database, researchers from Dana-Farber Cancer Institute found that serum galectin-1 levels "are significantly associated with tumor burden and additional adverse clinical characteristics in newly diagnosed Hodgkin lymphoma (HL) patients."
The measurements were made ...
When it comes to climate change, deforestation and toxic waste, the assumption has been that conservative views on these topics are intractable. But new research from the University of California, Berkeley, suggests that such viewpoints can be changed after all, when the messages about the need to be better stewards of the land are couched in terms of fending off threats to the "purity" and "sanctity" of Earth and our bodies.
A UC Berkeley study has found that while people who identified themselves as conservatives tend to be less concerned about the environment than ...
Violent acts in James Bond films were more than twice as common in Quantum of Solace (2008) than in the original 1962 movie Dr No, researchers from New Zealand's University of Otago have found.
The researchers analysed 22 official franchise films, which span 46 years, to test the hypothesis that popular movies are becoming more violent (The latest Bond film, Skyfall, was not included as it was unreleased at the time of the study).
They found that rates of violence increased significantly over the period studied and there was an even bigger increase in portrayals of ...
Infrared data from NASA's Aqua satellite have watched the strong thunderstorms in Typhoon Bopha fizzle and shrink in area over the weekend as wind shear increased. Bopha has now dissipated in the South China Sea, just west of Luzon, Philippines.
NASA's Aqua satellite has been providing data on Bopha since the day it formed on Nov. 26. In the storm's last days, Aqua's Atmospheric Infrared Sounder (AIRS) instrument captured infrared data of the storm and showed that cloud top temperatures warmed from Dec. 8 through Dec. 9 as cloud heights fell and thunderstorms lost their ...
NASA's Aqua satellite got "eyeballed" from Cyclone Claudia in the Southern Indian Ocean when two instruments captured the storm's eye in infrared and visible light. Satellite data indicates that Claudia's eye is about 10 nautical miles wide.
On Dec. 10 at 0841 UTC (3:41 a.m. EST), NASA's Aqua satellite's Atmospheric Infrared Sounder (AIRS) instrument captured an infrared view of Cyclone Claudia which showed a clear eye surrounded by powerful thunderstorms. The thunderstorms that surrounded the eye were high in the troposphere and cloud top temperatures topped -63 Fahrenheit ...
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of Hematology annual meeting.
The combination of two immunosuppressive compounds -- tacrolimus plus sirolimus -- did not provide a statistically significant, GVHD-free survival benefit over the long-used standard of care, tacrolimus plus methotrexate, said researchers from Dana-Farber Cancer Institute who led the multi-center trial.
However, there were ...
Public opinion on environmental issues such as climate change, deforestation, and toxic waste seems to fall along increasingly partisan lines. But new research suggests that environmental messages framed in terms of conservative morals — describing environmental stewardship in terms of fending off threats to the "purity" and "sanctity" of Earth and our bodies — may help to narrow the partisan gap.
A study from researchers at UC Berkeley has found that while people who identified themselves as conservatives tend to be less concerned about the environment than their liberal ...
COLUMBIA, Mo. – Medication reconciliation is a safety practice in which health care professionals review patients' medication regimens when patients transition between settings to reduce the likelihood of adverse drug effects. It is among the most complex clinical tasks required of physicians, nurses and pharmacists, who must work cooperatively to minimize discrepancies and inappropriate medication orders. Now, a University of Missouri gerontologiccal nursing expert suggests that acknowledging practitioners' varying perspectives on the purpose of medication reconciliation ...
ATLANTA - A two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.
Researchers presented the results today at the 54th annual meeting of the American Society of Hematology (ASH).
"This is a patient population with a great need for more targeted therapies," said Jan Burger, M.D., Ph.D., associate professor in MD Anderson's Department of Leukemia. Burger was lead author of ...
